About the Conference

Molecular diagnostics along with healthcare in general are undergoing technology-driven revolution, and we are at the beginning of this exciting journey. Novel detection assays and sensors, digital biomarkers and machine learning approaches have become key drivers for innovation in drug development and patient care. The channel will feature the latest technology breakthroughs as well as partnering, regulatory and reimbursement solutions for implementation into value-based patient-centered care.


A PDX/Organoid Biobank of Advanced Prostate Cancer for Disease Modeling and Therapeutic Screening

Kathleen KellyKathleen Kelly, PhD, Lab Chief, Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute

Advancing Cancer Diagnostics with Artificial Intelligence

Stumpe_MartinMartin Stumpe, PhD, Senior Vice President, Data Science, Tempus

QuPath: Digital Pathology for Everyone

Peter BankheadPeter Bankhead, PhD, Senior Lecturer, Digital Pathology, University of Edinburgh

A Digital Platform Integrating Disease and Risk Factor Surveillance, Genomics and Continuous Glucose Monitoring (CGM) to Estimate Personalized 10-Year Mortality Risk

Bradley PerkinsBradley A. Perkins, MD, Co-Founder & CEO, Sapiens Data Science, Inc.

Harnessing Patient Biology and Artificial Intelligence to Enable a Biomarker-Driven Personalized Medicine Approach

Niven NarainNiven R. Narain, PhD, Co-Founder, President & CEO, BERG

KEYNOTE PRESENTATION: Digital Health and the Wired Person

Michael Snyder, PhD, Professor & Chair, Center for Genomics & Personalized Medicine, Stanford University

KEYNOTE PRESENTATION: Understanding Disease State through Sensors/Wearables

Subramony_AnandAnand Subramony, PhD, Vice President, Novel Product Technologies, MedImmune

Register Now

Conference Programs